Intrinsic Value of S&P & Nasdaq Contact Us

Sonoma Pharmaceuticals, Inc. SNOA NASDAQ

NASDAQ Capital Marke • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
50/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — SNOA

Sonoma Pharmaceuticals, Inc. (SNOA) has a market capitalization of $3.88M and trades at $2.24. The 52-week range is 1.75-6.92.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.8, Earnings Per Share (EPS) of $-2.79, annual revenue of $14.29M.

The stock has a beta of 1.76, operates in the Healthcare sector.

Trading Data
Current Price$2.24
52-Week Range1.75-6.92
Volume11.98K
Avg Volume (30D)23.57K
Market Cap$3.88M
Beta (1Y)1.76
Company
IPO Date2007-01-25
Employees10
CEOAmy Trombly
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS83558L3033
CUSIP83558L303
Income (Latest Year)
Revenue$14.29M
Gross Profit$5.47M
EBITDA$-3.57M
Operating Income$-3.71M
Net Income$-3.46M
EPS$-2.79
EPS Diluted$-2.79
Shares Outstanding$1.24M
Balance Sheet (Latest Year)
Total Assets$13.69M
Current Assets$12.65M
Cash & ST Investments$5.37M
Total Liabilities$9.28M
Total Debt$305K
Net Debt$-5.07M
Total Equity$4.41M
Debt / Equity0.07
Valuation Ratios
P/E Ratio-0.8
P/S Ratio0.27
P/B Ratio0.88
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message